Menu
Washingtoner
  • Home
  • Financial
  • Home
  • Business
  • Construction
  • Crypto
  • Information Technology
  • Marketing
  • Education
Washingtoner

Gary S. Monroe, C.D. Accelerates Promising New Treatments For Cocaine And Methamphetamine Addicts
Washingtoner/10106757

Trending...
  • City of Spokane Seeks Applicants for Park Board
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
  • South Spokane Standoff Ends Peacefully After Suspect Surrenders to Officers
Accelerated Treatment Systems
SHERMAN OAKS, Calif. - Washingtoner -- Gary S. Monroe, C.D. (Clinical Director) for Accelerated Treatment Systems, in Sherman Oaks, California, recently met with Mike Pavlovich, PharmD, FAPhA, of Westcliff Compounding Pharmacy, in Newport Beach, California, to discuss several promising treatments for Cocaine and Methamphetamine addicts.

The discussion centered around several medications (GABAergic medications, such as baclofen, tiagabine, and topiramate, and the glutamatergic medication, modafinil.  Disulfiram, an old treatment for alcohol dependence, may also have efficacy for cocaine relapse prevention.) that block cocaine euphoria, or reduce cocaine craving and have shown potential to reduce the chances of relapse. Two studies regarding Methamphetamine addiction have shown promising results with the use of Naltrexone, Bupropion, and A118G Polymorphism.

Accelerated Treatment Systems plans on conducting several studies of their own with these treatments.  "We plan to get moving quickly, to bring hope to individuals who suffer from this debilitating issue and bring in the appropriate investment and scientific research," said Mr. Gary S. Monroe.

More on Washingtoner
  • Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
  • Proform Builds Completes Two Luxury Seattle Waterfront Renovation Projects
  • "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
  • City of Spokane Seeks Applicants for Park Board
  • South Spokane Standoff Ends Peacefully After Suspect Surrenders to Officers

About Gary S. Monroe
Gary S. Monroe is an Entrepreneur, an Entertainment Industry veteran, and the Founder of Accelerated Treatment Systems in Sherman Oaks, California, where he serves as Clinical Director.  He has been in recovery for 29 years.

https://www.linkedin.com/in/gary-monroe-lion-62449287

About Mike Pavlovich
Mike Pavlovich, PharmD, FAPhA is a Pharmacist and the President of Westcliff Compounding Pharmacy, a multi-disciplinary pharmaco-medical practice specializing in pain management and pharmaceutical compounding based in Newport Beach, California. Mr. Pavlovich served as a Trustee for the American Pharmacists Association from 2008-2014 and is a graduate of the University of the Pacific.

https://www.westcliffcompounding.com/index.html

About Accelerated Treatment Systems
Accelerated Treatment Systems is a Sherman Oaks, California, based Addiction treatment facility founded by Gary S. Monroe, C.D.

https://acceleratedtreatmentsystems.com/

Contact
Justin Waters
***@tonupinc.com


Source: Accelerated Treatment Systems

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
  • Plainsight Announces Jonathan Simkins as New CEO, Succeeding Kit Merker
  • Women's Everyday Safety Is Changing - The Blue Luna Shows How
  • Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
  • RollCraft Launches Pre-Roll Automation Machines for Producers Scaling Production in 2026
  • Spokane: Simple Police Contact for a Civil Bike Infraction Ends in Arrest After Suspect Flees from Officers; Stolen Property Recovered After Suspect is Taken into Custody
  • 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
  • The End of "Influencer" Gambling: Bonusetu Analyzes Finland's Strict New Casino Marketing Laws
  • AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue
  • TRIO Heating, Air & Plumbing Now Ranks #1 in San Jose
  • Milwaukee Job Corps Center Hosts Alumni Day, Calls Alumni to Action on Open Enrollment Campaign
  • Golden Paper Identifies Global Growth in Packaging Papers and Upgrades Its High-End Production Capacity
  • Tickeron Launches Advanced AI Corridor Bots with Up to 31% Returns Ahead of Key CPI Inflation Report
  • Tacoma: City Council Introduces Quality Jobs Framework to Help Strengthen Local Economy
  • Tacoma: City Council Approves Community & Economic Development Strategic Plan
  • A Statement from Mayor Victoria Woodards on Tacoma 2035 and the Community Safety Action Strategy
  • Tacoma: City Council Adopts Community Safety Action Strategy Built on Community Input
  • City Council Adopts 'Tacoma 2035'
  • Champagne, Caviar Bumps & Pole Performances — Welcome the New Year Early with HandPicked Social Club
_catLbl0 _catLbl1

Popular on Washingtoner

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 1615
  • City of Spokane Funds 50 New Shelter Beds, Mobile Medication Assisted Treatment Services
  • Dr. Alexander Eastman Returns to Suburban Hospital to Deliver Keynote on Crisis Leadership
  • The 7 Visibility Problems Costing Independent Hotels Thousands Every Month
  • New 2025–2026 Energy Rebates: Squeaks Services Explains How to Qualify
  • Revenue Optics Announces the Appointment of Sonal Chowdhury as Senior Manager – Strategic Operations
  • Cyntexa Announces Updates to ChargeOn on Salesforce AppExchange
  • How California Convinces Buyers Not to Purchase New Cars — and How This Hurts Dealers
  • Spokane City Council Votes on Modification For 2026 City Budget
  • Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2

Similar on Washingtoner

  • Women's Everyday Safety Is Changing - The Blue Luna Shows How
  • CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
  • New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
  • Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
  • Coalition and CCHR Call on FDA to Review Electroshock Device and Consider a Ban
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
  • FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
  • Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience
  • Signature Smiles Dental Group Unveils New User-Friendly Website
Copyright © 2025 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute